Introduction
The micronutrient chromium (Cr) has been established to have benefits on cattle immune function and growth performance (Page etal., 1993; Bernhard etal., 2012). Chromium is one of the most abundant minerals on earth and has been utilized as a dietary supplement more so in recent years. There are many sources of Cr; however, the only source that is approved for beef cattle supplementation is chromium propionate (FDA, 2019). Chromium is also available as Cr picolinate, Cr methionine, and Cr acetate (CrAc). Chromium supplementation has been shown to increase lean tissue while decreasing fat accumulation in hogs (Page etal., 1993; Mooney and Cromwell, 1995). Conversely, Tokach etal. (2015) reported that Cr propionate increased adipogenic gene expression and promoted adipogenic differentiation in Intramuscular (IM) adipocytes in cattle. Chromium has also been shown to affect insulin signaling and improve both glucose and amino acid uptake (Vincent, 2000). Insulin responsiveness is increased with the addition of Cr, thus increasing glucose uptake (Mertz, 1993; Hoffman etal., 2014). Chromium source can also potentially affect adenosine monophosphate (AMP)-activated protein kinase (AMPK) activity in vitro and in vivo (Penumathsa etal., 2009; Wang etal., 2009; Hoffman etal., 2014) via phosphorylation. Increased phosphorylation of AMPK in muscle tissue can trigger metabolic changes that switch the cell from energy storage to energy-consuming pathways (Tong etal., 2009). With this shift in cell signaling, energy can be provided to muscle tissue, which could affect myogenic gene expression, facilitating muscle growth and thus improving lean tissue marketed in the live animal.
Ohh and Lee (2005) state Cr supplementation with methionine could improve feed efficiency, glucose clearance, and insulin concentration in blood in well-nourished calves. However, this chelate is widely known not to have any adverse effect on growth performance (Ohh and Lee, 2005). The combination of Cr and methionine in a bovine satellite cell model has not been thoroughly explored. Therefore, this project aims to determine if there is an effect of gene expression, protein abundance, and amino acid uptake by incorporating Cr at normal and high levels on methionine uptake in cell culture.
Materials and Methods
Bovine satellite cell isolation
The isolation and cultivation of bovine satellite cells were conducted as previously reported by Johnson etal. (1998), Kim etal. (2018), and Kim etal. (2019). Three Angus steers, aged 16mo and weighing 47551.2kg, were processed at the Gordon W. Davis Meat Sciences Lab in Lubbock, TX, under USDA inspection. Upon harvest, approximately 800 g semimembranosus muscle tissue was collected and transported to the Meat Science and Muscle Biology laboratory at Texas Tech University. The tissue was transported in phosphate-buffered saline (PBS) containing 0.76M NaCl, 0.3M NaH2PO4 (pH 7.2), along with Antibiotic-Antimycotic (Gibco, Waltham, MA). The muscle tissue was isolated from vascular components, adipose tissue, and connective tissue, followed by homogenization using a sterile meat grinder. The acquired muscle tissue was incubated in Earls Balanced Salt Solution (EBSS; Sigma Aldrich, St. Louis, MO), augmented with 0.1% Pronase (Calbiochem, LaJolla, CA) at 37C. This mixture was subjected to intermittent agitation at 10-min intervals. After 1h of incubation, the mixture was centrifuged at 1,500g for 4min at room temperature. The resulting pellet was resuspended in PBS (Sigma Aldrich) and centrifuged at 500g for 10min at room temperature. The supernatant obtained from this step was collected and centrifuged at 1,500g for 10min at room temperature to isolate the mononucleated cells. The resulting mononucleated-cell preparation was suspended in Dulbeccos Modified Eagles medium (DMEM; Gibco) at 37C, supplemented with 10% fetal bovine serum (FBS) and 1 Antibiotic-Antimycotic (Gibco). The cells were incubated in a humidified atmosphere with 5% CO2 at 38C. This procedure was completed 3 separate times and cells were not pooled across animal.
Bovine satellite cell cultures
Cells were not counted but instead cultured until reaching approximately 70% to 80% confluency on a collagen matrix well plate. Induction of myogenic differentiation was achieved by replacing the existing medium with a differentiation medium containing DMEM supplemented with 2% FBS and 1 Antibiotic-Antimycotic. Both DMEM and FBS were from the same respective lots. There was no traceable level of Cr included in the DMEM formulation (Dulbecco and Freeman, 1959). Varying doses of additional methionine, 0mg/mL (differentiation media only; negative control [NC]), 1mg/mL, and 10mg/mL, and additional Cr, 0 M (differentiation media only; NC), 1.0 M, and 10.0 M as CrAc (Sigma Aldrich, USA) were added to the differentiation media. Cells were harvested at 24, 48, and 72h for the remaining analysis (Kim etal., 2018; Kim etal., 2019).
Fluorescence microscopy
For immunostaining, the cells were cultured on 3-well chamber microscopy glass slides (Cat. #: 80381, Ibidi, Fitchburg, WI) and incubated with different concentrations of methionine (0mg/mL and 10mg/mL) and CrAc (0 M and 10.0 M). To fix the slides, a 4% paraformaldehyde solution (Thermo Fisher Scientific) was applied at room temperature for 10min. To prevent nonspecific background staining, the fixed cells were incubated with 1% bovine serum albumin for 30min. Immunostaining was performed using a rabbit IgG polyclonal anti-GLUT4 antibody for glucose transporter 4 (GLUT4) and a mouse IgG2b polyclonal anti-insulin receptor antibody for the insulin receptor (IR). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI; Thermo Fisher Scientific) for 5min, followed by 2 washes with PBS. The slides were imaged using an inverted fluorescence microscope (Nikon Eclipse, Ti-E; Nikon Instruments Inc.) at a magnification of 20, equipped with a UV light source (Nikon Intensilight Inc.) (Kim etal., 2018; Kim etal., 2019).
RNA extractions
Following 48h of incubation with treatments, mRNA extraction was conducted utilizing TRIzol reagent (Invitrogen, Carlsbad, CA) as described in Kim etal. (2018). The quantification and assessment of mRNA purity were performed through spectrophotometric analysis at 260-nm and 280-nm wavelengths, employing a NanoDrop UV-Vis Spectrophotometer (Thermo Fisher Scientific).
Real-time quantitative PCR (7900HT Real-Time PCR System, Applied Biosystems, Foster City, CA) was used to measure the quantity of GLUT4, alpha serine/threonine-protein kinase (AKT), AMPK, myoblast determination protein 1 (MyoD), myogenin, and creatine phosphokinase (CPK) relative to the quantity of ribosomal protein subunit 9 (RPS9) mRNA (Table1). Primers were employed to target AMPK broadly rather than distinguish between the AMPK1 and AMPK2 isoforms. This decision was made to focus on the general activity and expression levels of AMPK to focus on AMPKs overarching contribution to the observed biological phenomena. This procedure was conducted as seen in Kim etal. (2019). Expression of RPS9 was not different across bovine tissue samples and was used as a housekeeping gene, as noted by Janovick-Guretzky etal. (2007) and Bionaz etal. (2007). The experiments were replicated 3 times, each consisting of 45 cycles that included a 15-s duration at 95C and a subsequent 1-min interval at 60C.
Genes1 | Sequence (5' to 3') |
---|---|
AMPK | |
Forward | ACCATTCTTGGTTGCTGAAACTC |
Reverse | CACCTTGGTGTTTGGATTTCTG |
TaqMan Probe | 6FAM-CAGGGCGCGCCATACCCTTG-TAMRA |
GLUT4 | |
Forward | CCTCGGCAGCGAGTCACT |
Reverse | AAACTGCAGGGAGCCAAGAA |
TaqMan Probe | 6FAM-CCTTGGTCCTTGGCGTATTCTCCGC-TAMRA |
AKT | |
Forward | TTGCCCATAACTAAGCCTACATCTC |
Reverse | GCAGGCGCTCTATGTACTGGAT |
TaqMan Probe | 6FAM-CCCAACCAGAGGCTGCCCAAAGT-TAMRA |
MyoD | |
Forward | AGGCCTTCGAGACGCTCAA |
Reverse | TGGCGTTGCGCAGGAT |
TaqMan Probe | 6FAM-CGCTGCACGTCTAGCAACCCAAACC-TAMRA |
Myogenin | |
Forward | AGAAGGTGAATGAAGCCTTCGA |
Reverse | GCAGGCGCTCTATGTACTGGAT |
TaqMan Probe | 6FAM-CCCAACCAGAGGCTGCCCAAAGT-TAMRA |
CPK | |
Forward | GCCAATGGACTGTTTTACAATGC |
Reverse | CCAAAGGGATTTTGTAGATGTTTCTC |
TaqMan Probe | 6FAM-TCATATTCCAGACGCATCTCCACAGCTACG-TAMRA |
RPS9 | |
Forward | GAGCTGGGTTTGTCGCAAAA |
Reverse | GGTCGAGGCGGGACTTCT |
TaqMan Probe | 6FAM-ATGTGACCCCGCGGAGACCCTTC-TAMRA |
AMPK: adenosine monophosphate-activated protein kinase-; GLUT4: glucose transporter 4; AKT: alpha serine/threonine-protein kinase; MyoD: myoblast determination protein 1; CPK: creatine phosphokinase; RPS9: ribosomal protein subunit 9.
Western blotting
After 48h of treatment, cellular lysates were prepared using the mammalian protein extraction (M-PER) (Thermo Fisher Scientific). Varying doses of methionine, 0mg/mL (differentiation media only; NC), 1mg/mL, and 10mg/mL, and Cr, 0 M (differentiation media only; NC), 1.0 M, and 10.0 M as CrAc (Sigma Aldrich, USA) were used as treatments. The quantification of total protein in these lysates was carried out via the bicinchoninic acid (BCA) assay (Thermo Fisher Scientific) with absorbance measurements at 562 nm using a NanoDrop UV-Vis Spectrophotometer. Samples were subsequently separated on a Bolt 4-12% Bis-Tris Plus gel (Thermo Fisher Scientific) under 200V for 22min. Following this, proteins were transferred to a nitrocellulose membrane using the iBlot 2 Dry Blotting System (Thermo Fisher Scientific). Primary antibodies used for anti- AMPK, anti-phosphorylated AMPK, and GLUT4 were rabbit polyclonal AB (Cell Signaling, Danvers, MA). Mouse polyclonal IgG2b (Cell Signaling, Danvers, MA) was used for IR. Primary antibody dilutions of 1:1,000 were used for this study. The secondary antibody for all proteins in this study was goat anti-rabbit with IgG2b used for IR and IgG for the remainder of the proteins observed. A 1:10,000 dilution was used for the secondary antibody. Membranes were dried and subsequently visualized with the VersaDoc Imaging System (Bio-Rad). Protein bands were identified and quantified using Bio-Rads Quantity One Band Analysis software. To ensure consistency, the intensity of each band was normalized against a pooled reference sample present on every blot. The mean intensity of each band was then calculated in relation to the NC to determine the level of phosphorylation.
Amino acid uptake
Cultured Bovine Satellite Cells (BSC) were allowed to reach approximately 80% confluency in a 96-well enzyme immunoassay/radioimmunoassay (EIA/RIA) plate (Corning Incorporated, Corning, NY). Custom differentiation media lacking methionine and arginine was added with varying doses of methionine, 0mg/mL (differentiation media only; NC), 1mg/mL, and 10mg/mL, and Cr, 0 M (differentiation media only; NC), 1.0 M, and 10.0 M as CrAc (Sigma Aldrich, USA) as treatments. There was no traceable level of Cr included in the DMEM formulation (Dulbecco and Freeman, 1959). Arginine was added at a fixed rate for all cells. Multiple wells were not seeded with cells in order to serve as blank measurements and used as a correction in final calculations. Cell media was collected from wells at 24, 48, 72, and 96h. Cells were seeded into the 96-well plate and conditioned media was harvested only once from each well. Once media was harvested, the wells were discarded and therefore not considered a repeated measure. Free amino acids were determined using the EZ:faast amino acid analysis kit (Phenomenex, Torrance, CA) and gas chromatography-mass spectrometry at a 1:15 split ratio using helium as carrier gas on a Zebron ZB-AAA Gas Chromatography (GC) column. The GC oven was set to increase 30C/min, starting at 110C with a final temperature of 320C. Values from gas chromatography are described using the assumption that a decrease in values over time corresponds to an increase in Amino Acid (AA) disappearance in the media. In this highly controlled environment, this disappearance could be attributed to AA absorption by the cell.
Equation1. Determination of chromatography results where PAPeak Area and ISequal Norvaline internal standard.
Statistical analysis
For all analyses, cells were isolated from steers, and animal was considered an experimental unit. Cell wells were treated independently and replicated within each animal based on power. A two-tailed power test was run using SAS (SAS Inst., Inc., Cary, NC) with 0.8. Within the gene expression experiment, wells were replicated 4 times. In the amino acid update experiment, cell wells were replicated 6 times, and protein wells were replicated 4 times. Each replication was repeated across animal. Data were analyzed using the GLM procedure of SAS. Treatment and time were included as fixed effects. If interactions were not present, they were removed from the model. For gene expression and protein abundance experiments, a two-way ANOVA was used to determine interactions with methionine and Cr. Amino acid experiments utilized a 22 factorial ANOVA to determine time effects. P0.05 was considered significant, and tendencies were defined as P0.05 but0.1.
Results and Discussion
There was no observable difference in GLUT4 and IR based on immunohistochemistry staining (Figures12) or Western blot (Figures3 to 4) (P>0.1). The addition of 10 M of CrAc tended to downregulate AMPK (P<0.1; Figure5) but did not produce differences in protein accumulationbut did not produce differences in protein accumulation (P>0.1; Figure6). Myogenin was not impacted by both methionine or CrAc with high doses, and low doses did not alter gene expression (P<0.01; Figure7). Treatments with varying levels of dosage, high methionine plus low CrAc and low methionine and high CrAc, downregulated myogenin expression (P<0.01). Myogenin initiates terminal differentiation in satellite cells. The downregulation of myogenin seen in this study by mixed treatment groups suggests that both methionine and Cr work in tandem to promote the differentiation of satellite cells. Ohh and Lee (2005) provided support for this concept by observing that chromium methionine chelate (CrMet) can directly cross the intestinal cell membrane without the need for prior digestion. Tsa and Lien (2007) saw no effect on myogenin in myoblasts using Cr picolinate with other organically bound Cr sources.
All other genes measured in this study were not affected (P>0.1; Figures810). The ratio of AMPK:pAMPK, GLUT4, and IR abundance were also not affected (P>0.1). Qiao etal. (2009) observed contradicting results as the inclusion of Cr in various forms upregulated the expression of GLUT4 and IR in rat L6 cells. Okada etal. (1983) demonstrated that Cr(III) specifically enhances RNA synthesis without affecting the nucleotide pool. It has been shown that Cr does have an impact on the phosphorylation of Akt (Dong etal., 2009); however, there was no difference regarding up- or downregulation (P>0.1) in this study. Roos etal. (2009) also observed an unaffected AMPK pathway and expression of S6K1 with the treatment of glucose-deprived cells. While glucose deprivation was not a treatment in the current experiment, high Cr treatments could increase glucose clearance levels (Bunting etal., 1994). Kegley etal. (2000) observed results indicating that Cr fed as chromium-L-methionine increased glucose clearance rate in steers.
Free amino acids in cultured media displayed various main effects with select interactions. An increase of time saw a significant decrease in leucine, isoleucine, threonine, methionine, phenylalanine, glutamine, ornithine, lysine, and cystine (P<0.01). Over time, alanine increased (P<0.01; Table2). The inclusion of methionine as a treatment saw an increase in alanine, proline, glutamic acid, and ornithine, as well as a decrease in leucine, isoleucine, and cystine (P<0.01; Table3). Lysine was different based on methionine inclusion (P<0.01). As time progressed, the need for various amino acids changes (Mary etal. 2008). New amino acids are needed for protein synthesis and therefore can be taken in by the cell via their requisite transporters. Cells also may perish and lyse their membrane, thereby releasing its contents, which can include amino acids such as the ones observed in this study. An interaction of methionine and time was observed in methionine and tryptophan concentrations (P<0.01; Figures1112). Tryptophan concentrations in the free media decreased over time in the 0mg/mL treatment group.
Time, h | SEMa | P Value | ||
---|---|---|---|---|
Amino Acid, ng/ml | 24 | 48 | ||
Alanine | 17.99 | 32.72 | 1.341 | <0.01 |
Glycine | 53.27 | 56.90 | 6.725 | 0.69 |
Valine | 69.94 | 72.56 | 2.296 | 0.42 |
Leucine | 71.18 | 62.32 | 1.775 | <0.01 |
Isoleucine | 81.98 | 74.60 | 2.399 | 0.03 |
Threonine | 95.68 | 52.46 | 7.361 | <0.01 |
Proline | 4.87 | 7.53 | 0.268 | <0.01 |
Aspartate | 1.78 | 2.19 | 0.436 | 0.32 |
Methionine | 70.73 | 49.82 | 6.903 | 0.01 |
Hydroxyproline | 4.61 | 4.01 | 0.422 | 0.37 |
Glutamic Acid | 37.80 | 31.69 | 2.789 | 0.17 |
Phenylalanine | 44.08 | 34.80 | 2.586 | <0.01 |
Cysteine | 154.3 | 155.63 | 20.00 | 0.65 |
Glutamine | 0.04 | 0.01 | 0.004 | <0.01 |
Ornithine | 2.61 | 1.07 | 0.231 | <0.01 |
Lysine | 69.53 | 39.63 | 7.066 | <0.01 |
Histidine | 26.03 | 26.79 | 1.899 | 0.62 |
Tyrosine | 39.04 | 33.62 | 2.442 | 0.09 |
Tryptophan | 4.48 | 3.67 | 0.313 | 0.09 |
Cystine | 9.03 | 4.93 | 0.567 | <0.01 |
Pooled standard error of the mean.
Methionine, mg/mL | ||||
---|---|---|---|---|
Amino Acid, ng/mL | 0 | 10 | SEMa | P Value |
Alanine | 23.42 | 27.30 | 1.341 | <0.01 |
Glycine | 52.70 | 57.57 | 6.725 | 0.47 |
Valine | 75.03 | 67.47 | 2.296 | 0.79 |
Leucine | 71.62 | 61.88 | 1.775 | <0.01 |
Isoleucine | 83.64 | 72.94 | 2.399 | <0.01 |
Threonine | 68.01 | 80.13 | 7.361 | 0.33 |
Proline | 5.92 | 6.48 | 0.268 | 0.05 |
Aspartate | 1.72 | 2.24 | 0.436 | 0.41 |
Hydroxyproline | 3.78 | 4.84 | 0.422 | 0.07 |
Glutamic Acid | 26.53 | 42.95 | 2.789 | <0.01 |
Phenylalanine | 39.41 | 39.48 | 2.586 | 0.77 |
Cysteine | 148.85 | 161.13 | 20.003 | 0.97 |
Glutamine | 0.02 | 0.03 | 0.004 | 0.25 |
Ornithine | 1.06 | 2.69 | 0.231 | <0.01 |
Lysine | 6.90 | 102.26 | 7.066 | <0.01 |
Histidine | 26.56 | 26.25 | 1.899 | 0.81 |
Tyrosine | 36.11 | 36.54 | 2.442 | 0.94 |
Cystine | 7.42 | 6.55 | 0.567 | 0.07 |
Pooled standard error of the mean.
Chromium acetate only affected 3 amino acids (P<0.01; Table4). CrAc and time interactions were present in cysteine and lysine concentrations (P<0.01; Figures1314). Previous research has shown that Cr has effects on increasing amino acid absorption and incorporation by various cell types. Roginski and Mertz (1969) found that incorporating Cr into the drinking water of rats increased amino acid incorporation in cardiac muscle. Dong etal. (2009) showed that supplementing Cr inhibited muscle atrophy associated with muscle disuse in rat hind limbs. A potential explanation of this observation is the effect Cr has on protein uptake. Chromium is known to affect the mammalian target of rapamycin (mTOR) pathway (Brautigan etal., 2006). The low-molecular-weight Cr-binding substance, known as chromodulin, potentiates the effects of insulin. Insulin is stimulated by chromodulin without altering the concentration of insulin required for half-maximal activity (Vincent, 2018). Insulin is released rapidly into the bloodstream to raise blood sugar levels. Insulin binds with the external subunit of the transmembrane protein IR, leading to a conformational change in the receptor. This conformational change triggers the autophosphorylation of tyrosine residues on the internal portion of the receptors subunit, thereby activating the receptor as a kinase (Saltiel, 1994). Increasing phosphorylation of the IR is one mode of action that activates mTOR, which begins a cascade of events that ends with nutrient absorption and transcription of new proteins. This increase in protein synthesis in the cells could have increased the need for the amino acid influx in cells from this study. Free amino acids can also affect their corresponding transporters. A high concentration of methionine and lysine could affect the S and L amino acid transporter families (SAT and LAT), respectively (Hyde etal., 2003). Chromium itself could have had an effect on uptake, specifically on cysteine. The reduction of Cr(VI) to Cr(III) in natural aqueous solutions is facilitated by cysteine (Lay and Levina, 1996). By increasing Cr supplemented to the cell, the cell may have consumed cysteine to prepare for the reduction of Cr(VI) should it be necessary.
Cr Dose, M | |||||
---|---|---|---|---|---|
Amino Acid, ng/mL | 0 | 0.1 | 10 | SEMa | P Value |
Alanine | 28.21x | 23.35y | 24.52xy | 1.774 | 0.02 |
Glycine | 64.81 | 49.31 | 51.13 | 8.897 | 0.21 |
Valine | 71.85 | 69.77 | 72.13 | 3.038 | 0.56 |
Leucine | 65.95 | 67.49 | 66.80 | 2.348 | 0.83 |
Isoleucine | 78.81 | 77.04 | 79.02 | 3.017 | 0.81 |
Threonine | 72.42 | 76.51 | 73.28 | 9.738 | 0.81 |
Proline | 6.47 | 5.99 | 6.13 | 0.355 | 0.40 |
Aspartate | 1.84 | 2.17 | 1.94 | 0.577 | 0.85 |
Methionine | 57.35 | 67.83 | 55.63 | 9.132 | 0.48 |
Hydroxyproline | 4.08 | 4.79 | 4.06 | 0.558 | 0.49 |
Glutamic Acid | 34.79 | 34.91 | 34.53 | 3.689 | 0.77 |
Phenylalanine | 37.36 | 42.53 | 38.44 | 3.421 | 0.38 |
Glutamine | 0.02x | 0.03x | 0.04y | 0.005 | <0.01 |
Ornithine | 1.83 | 1.97 | 1.72 | 0.306 | 0.71 |
Histidine | 25.46 | 28.28 | 25.48 | 2.513 | 0.53 |
Tyrosine | 34.03 | 40.08 | 34.87 | 3.231 | 0.26 |
Tryptophan | 3.54x | 4.18x | 4.52y | 0.414 | 0.02 |
Cystine | 6.24 | 7.81 | 6.88 | 0.750 | 0.15 |
Within a row, means that do not have a common superscript differ (P<0.05).
Pooled standard error of the mean.
Higher levels of these amino acids in the media could increase receptor number, increasing amino acid uptake (Christie etal., 2001; Hyde etal., 2003). The SAT, which is sodium independent, can use glycine, alanine, serine, cysteine, asparagine, arginine, methionine, and proline as substrates. The LAT, which is sodium dependent, can use histidine, methionine, leucine, threonine, isoleucine, and glutamine as substrates for transport (Hyde etal., 2003). Specifically, the LAT1 (or SLC43A2) transporter also can affect mTORC1 activity by supplying leucine to the cell (Salisbury and Arthur, 2018). Milkereit etal. (2015) indicated that LAT1 associates with the cell membrane as well as mediates leucine transfer into the lysosome. Leucine is the most effective amino acid activator of mTORC1 (Saxton and Sabatini, 2017). This increase in the available substrate may have affected the amino acid transporters and allowed for an increase in amino acid absorption. The increase in leucine over time in this study could have also stimulated the mTOR pathway, thereby helping stimulate activity. Using this method in future studies would be beneficial to further elucidate the mode of action of different transporters in cultured media.
Conclusions
Chromium and methionine have been shown to affect nutrient uptake and gene expression in multiple studies. While the results from this study have not solidified the essentiality of Cr, it has been shown through novel techniques that Cr can affect specific amino acids absorbed into the cell. This study elucidates some of the effects both Cr and methionine have on bovine satellite cells. The authors of this study believe the EZ:faast quantification method on cultured media is a valuable asset to expand the quantification capabilities of researchers in the muscle biology field, but further quantification and replication are needed. Further research is needed to elucidate the full effects of these compounds in tandem and how they affect cells from other species. Live animal research can also be used to determine whether these effects are observed in vivo.
Acknowledgments
The authors certify there are no conflicts of interest in the conduction of this research or preparation of this document. P.M.U. and J.K. provided the main text of this document. P.M.U., J.K., L.K.F., K.B.W., and S.N.B. conducted the procedures in the laboratory. B.J.J. and J.F.L. supported this research as well as provided editorial remarks.
Literature Cited
Bernhard, B. C., N. C. Burdick, W. Rounds, R. J. Rathmann, J. A. Carroll, D. N. Finck, and B. J. Johnson. 2012. Chromium supplementation alters the performance and health of feedlot cattle during the receiving period and enhances their metabolic response to a lipopolysaccharide challenge. J. Anim. Sci. 90:38793888. doi: https://doi.org/10.2527/jas.2011-4981
Bionaz, M., and J. J. Loor. 2007. Identification of reference genes for quantitative real-time PCR in the bovine mammary gland during the lactation cycle. Physiol. Genomics 29:312319.
Brautigan D. L., A. Kruszewski, and H. Wang. 2006. Chromium and vanadate combination increases insulin-induced glucose uptake by 3T3-L1 adipocytes. Biochem. Bioph. Res. Co. 347:769773.
Bunting, L. D., J. M. Fernandez, D. L. Thompson Jr, and L. L. Southern. 1994. Influence of chromium picolinate on glucose usage and metabolic criteria in growing Holstein calves. J. Anim. Sci. 72:15911599.
Christie, G. R., R. Hyde, and H. S.Hundal. 2001. Regulation of amino acid transporters by amino acid availability. Curr. Opin. Clin. Nutr. 4:425431.
Dong, F., Y. Hua, P. Zhao, J. Ren, M. Du, and N. Sreejayan. 2009. Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice. J. Nutr. Biochem. 20:992999.
Dowling, H. J., E. G. Offenbacher, and F. X. Pi-Sunyer. 1989. Absorption of inorganic, trivalent chromium from the vascularly perfused rat small intestine. J. Nutr. 119:11381145.
Dulbecco, R., and G. Freeman. 1959. Virology 8:396.
FDA (US Food and Drug Administration). 2019. Sec. 573.304 Chromium Propionate [CFR Title 21]. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr573.304 (Updated 22 December 2023; Accessed 21 May 2024).https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr573.304
Hoffman, N. J., B. A. Penque, K. M. Habegger, W. Sealls, L. Tackett, and J. S. Elmendorf. 2014. Chromium enhances insulin responsiveness via AMPK. J. Nutr. Biochem. 25:565572.
Hyde, R., P. M. Taylor, and H. S. Hundal. 2003. Amino acid transporters: Roles in amino acid sensing and signalling in animal cells. Biochem. J. 373:118.
Johnson, B. J., N. Halstead, M. E. White, M. R. Hathway, A. DiCostanzo, and W. R. Dayton. (1998). Activation state of muscle satellite cells isolated from steers implanted with a combined trenbolone acetate and estradiol implant. Journal of animal science, 76(11), 27792786.
Janovick-Guretzky, N. A., H. M. Dann, D. B. Carlson, M. R. Murphy, J. J. Loor, and J. K. Drackley. 2007. Housekeeping gene expression in bovine liver is affected by physiological state, feed intake, and dietary treatment. J. Dairy Sci. 90:22462252.
Kegley, E. B., D. L. Galloway, and T. M. Fakler. 2000. Effect of dietary chromium-L-methionine on glucose metabolism of beef steers. J. Anim. Sci. 78:31773183.
Kim, J., K. Y. Chung, B. J. Johnson, and S. B. Smith. 2019. PSXIV-32 Oleic acid stimulate the formation of adipocyte-like cells from bovine satellite cells via G Protein Coupled Receptor 43 and CCAAT/Enhancer Binding Protein Beta. J. Anim. Sci. 97:308309.
Kim, J., K. B. Wellmann, Z. K. Smith, and B. J. Johnson. 2018. All-trans retinoic acid increases the expression of oxidative myosin heavy chain through the PPAR pathway in bovine muscle cells derived from satellite cells. J. Anim. Sci. 96:27632776.
Lay, P. A., and A. Levina. 1996. Kinetics and mechanism of chromium (VI) reduction to chromium (III) by L-cysteine in neutral aqueous solutions. Inorg. Chem. 35:77097717.
Lien, T. F., C. P. Wu, B. J. Wang, M. S. Shiao, T. Y. Shiao, B. H. Lin, and C. Y. Hu. 2001. Effect of supplemental levels of chromium picolinate on the growth performance, serum traits, carcass characteristics and lipid metabolism of growing-finishing pigs. Anim. Sci. 72:289296.
Mary, I., L. Garczarek, G. A. Tarran, C. Kolowrat, M. J. Terry, D. J. Scanlan, P. H. Burkill, and M. V. Zubkov. 2008. Diel rhythmicity in amino acid uptake by Prochlorococcus. Environ. Microbiol. 10:21242131.
Mertz, W. 1993. Chromium in human nutrition: A review. J. Nutr. 123:626633.
Milkereit, R., A. Persaud, L. Vanoaica, A. Guetg, F. Verrey, and D. Rotin. 2015. LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation. Nat. Commun. 6:19.
Mooney, K. W., and G. L. Cromwell. 1995. Effects of dietary chromium picolinate supplementation on growth, carcass characteristics, and accretion rates of carcass tissues in growing-finishing swine. J. Anim. Sci. 73:33513357.
Ohh, S. J., and J. Y. Lee. 2005. Dietary chromium-methionine chelate supplementation and animal performance. Asian Austral. J. Anim. 18:898907.
Okada, S., M. Suzuki, and H. Ohba. 1983. Enhancement of ribonucleic acid synthesis by chromium (III) in mouse liver. J. Inorg. Biochem. 19:95103.
Page, T. G., L. L. Southern, T. L. Ward, and D. L. Thompson Jr . 1993. Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs. J. Anim. Sci. 71:656662.
Penumathsa, S. V., M. Thirunavukkarasu, S. M. Samuel, L. Zhan, G. Maulik, M. Bagchi, and N.Maulik. 2009. Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. BBA-Mol. Basis Dis. 1792:3948.
Qiao, W., Z. Peng, Z. Wang, J. Wei, and A. Zhou. 2009. Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells. Biol. Trace Elem. Res. 131:133142.
Roginski, E. E., and W. Mertz. 1969. Effects of chromium (III) supplementation on glucose and amino acid metabolism in rats fed a low protein diet. J. Nutr. 97:525530.
Roos, S., O. Lagerlf, M. Wennergren, T. L. Powell, and T. Jansson. 2009. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. Am. J. Physiol.-Cell Ph. 297:C723C731.
Salisbury, T. B., and S. Arthur. 2018. The regulation and function of the L-type amino acid transporter 1 (LAT1) in cancer. Int. J. Mol. Sci. 19:2373.
Saltiel, A. R. 1994. The paradoxical regulation of protein phosphorylation in insulin action. FASEB J. 8:10341040.
Saxton, R. A., and D. M. Sabatini. 2017. mTOR signaling in growth, metabolism, and disease, Cell 169:361371.
Tokach, R. J., F. R. Ribeiro, K. Y. Chung, W. Rounds, and B. J. Johnson. 2015. Chromium propionate enhances adipogenic differentiation of bovine intramuscular adipocytes. Frontiers in Veterinary Science 2:26.
Tong, J. F., X. Yan, M. J. Zhu, S. P. Ford, P. W. Nathanielsz, and M. Du. 2009. Maternal obesity downregulates myogenesis and -catenin signaling in fetal skeletal muscle. Am. J. Physiol.-Endoc. M. 296:E917E924.
Tsa, M. C., T. F. Lien. 2007. Chromium Picolinate did not Effect on the Proliferation and Differentiation of Myoblasts. Am. J. Anim. Vet. Sci, 2: 7983.
Vincent, J. B. 2000. The biochemistry of chromium. J. Nutr. 130:715718.
Vincent, J. B. (Ed). 2018. The nutritional biochemistry of chromium (III). Elsevier, Amsterdam. Second Edition.
Wang, Y. Q., Y. Dong, and M. H. Yao. 2009. Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of AMP-activated protein kinase. Clin. Exp. Pharmacol. P. 36:843849.